Amgen (AMGN) Receivables - Other (2013 - 2024)

Amgen (AMGN) has reported Receivables - Other for 8 consecutive years, with $198.0 million the latest figure, recorded in Q4 2024.

• In Q4 2024, Receivables - Other fell 60.56% year-over-year to $198.0 million; the TTM figure through Dec 2024 stood at $198.0 million (down 60.56% YoY), while the FY2024 annual figure was $198.0 million, down 60.56% from the prior year.
• Receivables - Other came in at $198.0 million for Q4 2024 at Amgen, down from $502.0 million in the prior quarter.
• The five-year high for Receivables - Other was $583.0 million in Q4 2020, with the low at $61.0 million in Q4 2021.
• Average Receivables - Other over 5 years is $294.6 million, with a median of $198.0 million recorded in 2024.
• Across the five-year window, Receivables - Other slumped 89.54% in 2021 and jumped 289.15% in 2023, its largest moves.
• Year by year, Receivables - Other stood at $583.0 million in 2020, then plunged by 89.54% to $61.0 million in 2021, then soared by 111.48% to $129.0 million in 2022, then surged by 289.15% to $502.0 million in 2023, then slumped by 60.56% to $198.0 million in 2024.
• According to Business Quant data, Receivables - Other over the past three periods registered $198.0 million, $502.0 million, and $129.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.